Oxaliplatin based chemotherapy and concomitant highly active antiretroviral therapy in the treatment of 24 patients with colorectal cancer and HIV infection

Current HIV Research

Volumn 8, Issue 3, 2010, Pages 218-222

  Berretta, Massimiliano ^a   Lleshi, Arben ^a   Cappellani, Alessandro ^b   Bearz, Alessandra ^a   Spina, Michele ^a   Talamini, Renato ^a   Cacopardo, Bruno ^b   Nunnari, Giuseppe ^b   Montesarchio, Vincenzo ^c   Izzi, Immacolata ^d   Lanzafame, Massimiliano ^e   Nasti, Guglielmo ^f   Basile, Francesco ^b   Berretta, Salvatore ^b   Fisichella, Rossella ^b   Schiantarelli, Clara C ^g   Garlassi, Elisa ^h   Ridolfo, Annalisa ⁱ   Guella, Lorenza ^j   Tirelli, Umberto ^a  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

^c AO Dei Colli Hospital for Infectious Diseases D Cotugno   (Italy)

^d FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^e UNIVERSITY OF VERONA   (Italy)

^f NATIONAL CANCER INSTITUTE   (Italy)

^g Division of Infectious Disease   (Italy)

^h UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

ⁱ UNIVERSITY OF MILAN   (Italy)

^j Division of Infectious Disease   (Italy)

more..

Author keywords

Chemotherapy; FOLFOX4; HAART; HIV infection; Metastatic colorectal cancer; Treatment

Indexed keywords

COTRIMOXAZOLE; FLUOROURACIL; FOLINIC ACID; GRANULOCYTE COLONY STIMULATING FACTOR; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; OXALIPLATIN; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTINEOPLASTIC AGENT; FOLFOX PROTOCOL; PLATINUM COMPLEX;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; COLORECTAL CANCER; DIARRHEA; DRUG ACTIVITY; DRUG RESPONSE; DRUG TOLERABILITY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MALE; METASTASIS; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUTROPENIA; OPPORTUNISTIC INFECTION; PNEUMOCYSTIS PNEUMONIA; SEROLOGY; COLORECTAL TUMOR; DRUG THERAPY; ITALY; METHODOLOGY; MIDDLE AGED; TREATMENT OUTCOME;

ADULT; ANTI-HIV AGENTS; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; COLORECTAL NEOPLASMS; DRUG THERAPY; FEMALE; FLUOROURACIL; HIV INFECTIONS; HUMANS; ITALY; LEUCOVORIN; MALE; MIDDLE AGED; ORGANOPLATINUM COMPOUNDS; TREATMENT OUTCOME;

EID: 77954050860     PISSN: 1570162X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157016210791111061     Document Type: Article

References (27)

1. Wasserberg N, Nunoo-Mensah JW, Gonzalez-Ruiz C, Beart RW Jr, Kaiser AM. Colorectal cancer in HIV-infected patients: a case control study. Int J Colorectal Dis 2007; 22: 1217-21.
2. Levine AM. AIDS-related malignancies: The emerging epidemic. J Natl Cancer Inst 1993; 85: 1382-97.
3. Wang CY, Snow JL, Su WP. Lymphoma associated with human immunodeficiency virus infection. Mayo Clin Proc 1995; 70: 665-72.
4. Berretta M, Cinelli R, Martellotta F, Spina M, Vaccher E, Tirelli U. Therapeutic approaches to AIDS-related malignancies. Oncogene 2003; 22: 6646-59.
5. Chiao EY, Krown SE. Update on non-acquired immuno-deficiency syndrome-defining malignancies. Curr Opin Oncol 2003; 15: 389-97.
6. Cooley TP. Non-AIDS-defining cancer in HIV-infected people. Hematol Oncol Clin N Am 2003; 17: 889-99.
7. Bonnet F, Lewden C, May T, et al. Malignancies-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy. Cancer 2004; 101: 317-24.
8. Cooksley CD, Hwang LY, Waller DK, Ford CE. HIV-related malignancies: community-based study using linkage of cancer registry and HIV registry data. Int J STD AIDS 1999; 10: 795-802.
9. Bedimo R, Chen RY, Accortt NA, et al. Trends in AIDS-defining and non-AIDS-defining malignancies among HIV-infected patients: 1989-2002. Clin Infect Dis 2004; 39: 1380-4.
10. Yeguez JF, Martinez SA, Sands LR, Hellinger MD. Colorectal malignancies in HIV-seropositive patients. Am Surg 2003; 69: 981-7.
11. Patel P, Hanson DL, Sullivan PS, et al. Incidence of Types of cancer among HIV-Infected persons compared with the general population in the United States, 1992-2003. Ann Intern Med 2008; 48: 728-36.
12. Bini ED, Park J, Francois F. Use of flexible sigmoidoscopy to screen for colorectal cancer in HIV-infected patients 50 years of age and older. Arch Intern Med 2006; 166: 1626-31.
13. Bray F, Sankila R, Ferlay J, Parkin DM. estimates of cancer incidence and mortality in Europe in 1995. Eur J Cancer 2002; 38: 99-166.
14. Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 2007; 18: 581-92.
15. Folprecht G, Grothey A, Alberts S, Raab HR, Kohne CH. Neoajuvant treatment of unrectable colorectal liver metastases: correlation between tumour response and resection rates. Ann Oncol 2005; 16: 1311-9.
16. de Gramont A, Figer A, Seymour M, et al. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 2000; 18: 2938-47.
17. Berretta M, Di Benedetto F, Simonelli C, et al. Multidisciplinary approach in HIV/HCV-positive patient with liver metastases by colorectal cancer in the HAART era. Ann Oncol 2006; 17: 1333-4.
18. Berretta M, Simonelli C, Lleshi A, et al. Oxaliplatin-based chemotherapy in association with highly active antiretroviral therapy in metastatic colorectal cancer HIV-infected patients. Ann Oncol 2006; 17: 721-2.
19. Berretta M, Martellotta F, Simonelli C, et al. Cetuximab/targeted chemotherapy in an HIV-positive patient with metastatic colorectal cancer in the HAART era: a case report. J Chemother 2007; 19: 343-6.
20. Centers for Disease Control "1993 revised classification system for HIV infection and expands surveillance case definition for AIDS adolescents and adults". MMWR 1992; 41: 1-18.
21. WHO criteria. WHO handbook for reporting results of cancer treatment. Geneva, World Health Organization, Offset publication No. 48, 1979.
22. Kaplan EL, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-81.
23. Armitage P, Berry G, Matthews JNS. Statistical Methods in Medical Research. Blackwell Sc. Publication 2002.
24. Berretta M, Martellotta F, Spina M, et al. Clinical features and outcome of colorectal cancer in HIV-infected people: a GICAT experience [Abstract]. Gastrointestinal Cancers Symposium - Am Soc Clin Oncol GI Meeting 2005; Abstract # 201.
25. Cappell MS, Yao F, Cho KC. Colonic adenocarcinoma associated with the acquired immune deficiency syndrome. Cancer 1988; 62: 616-9.
26. Klugman AD, Schaffner J. Colon adenocarcinoma in HIV infection: A case report and review. Am J Gastroenterol 1994; 89: 254-6.
27. Yeguez JF, Martinez S, Sands DR, Sands LR, Hellinger MD. Colorectal malignancies in HIV-positive patients. Am Surg 2003; 11: 981-7.